Nathalie Y. Rosin

The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

V. Gandhi, J. Burger, M. Keating, 2015, Leukemia.

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.

A. Rosenwald, H. Kantarjian, Xuelin Huang, 2014, The Lancet. Oncology.

Activity of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) in B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Z. Estrov, H. Kantarjian, F. Ravandi, 2012 .

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization.

Michael J Keating, M. Keating, J. Burger, 2014, Blood.

chemosensitization chronic lymphocytic leukemia cell motility and causes The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with

J. Burger, C. Maasch, W. Wierda, 2014 .